KRAS and pancreatic neoplasm: However, we noticed that in the case of KrasG12D in the pancreatic cancer HPAF-II cell line, the silencing of KrasG12D using Kras shRNA could increase FL118-induced apoptosis [21], suggesting that KrasG12D in HPAF-II cells is somewhat of a resistant factor for FL118.